Minoxidil for Hair Loss: Comparing Topical and Oral Options
For those dealing with thinning hair, minoxidil is one of the most recognized treatments available. Whether applied as a foam or taken as a pill, this medication aims to combat androgenetic alopecia (AGA)—the common form of pattern hair loss affecting both men, and women. While topical versions are widely available over-the-counter, low-dose oral versions have gained popularity as off-label alternatives.
- Topical Minoxidil: FDA-approved for men and women in 2% and 5% concentrations (solution and foam).
- Oral Minoxidil: Not FDA-approved for hair loss; used off-label at low doses (0.5–5 mg/day).
- Efficacy: Some studies suggest low-dose oral minoxidil is more effective than topical versions for male AGA.
- Mechanism: Works as a vasodilator and anti-inflammatory agent to promote hair regrowth.
Topical Minoxidil: The FDA-Approved Standard
Topical minoxidil, commonly known by the brand name Rogaine, received FDA approval for the treatment of hair loss in 1991. It is available in 2% and 5% concentrations, offered as both solutions and foams.
How It Works
Minoxidil is a prodrug. When applied to the scalp, it is metabolized by follicular sulfotransferase into minoxidil sulfate, which is the active form of the medication. Only about 1.2% to 1.4% of the topical application is absorbed through the skin. It functions through several pathways: acting as a vasodilator, an anti-inflammatory agent, an antiandrogen, and an inducer of the Wnt/β-catenin signaling pathway. These actions help increase hair counts and may affect the length of the hair’s anagen (growth) and telogen (resting) phases.
Clinical Efficacy
Topical minoxidil promotes regrowth in the vertex and frontotemporal areas of the scalp. Research indicates that while 2% minoxidil shows peak hair growth in males at the one-year mark, this effect may decline in subsequent years. Interestingly, the 5% solution and foam have not shown a significant difference in efficacy compared to the 2% solution.
Oral and Sublingual Minoxidil: Off-Label Use
While topical treatments are the standard, some providers prescribe oral or sublingual minoxidil. Oral minoxidil is officially FDA-approved as a blood pressure medication (Loniten) and is used off-label for hair loss.
Dosage and Effectiveness
For hair loss, physicians typically prescribe low doses, ranging from 0.5 to 5 mg per day. This low-dose regimen may be safe and effective for female pattern hair loss and chronic telogen effluvium. In men with AGA, a dose of 5 mg/day has been found significantly more effective than 2% or 5% topical minoxidil after six months of administration.
Pharmacokinetics of Oral Minoxidil
Unlike the topical version, oral minoxidil has a high bioavailability of 90% or more. It is absorbed quickly, with a peak onset of action between 30 and 60 minutes. The drug is primarily metabolized in the liver and excreted via urine (over 97%).
Comparing Minoxidil Delivery Methods
| Feature | Topical Minoxidil | Oral Minoxidil (Off-Label) |
|---|---|---|
| FDA Approved for Hair Loss | Yes | No (Approved for Hypertension) |
| Absorption | ~1.2–1.4% (Skin) | ≥90% (Oral) |
| Application | Liquid or Foam | Tablet/Pill |
| Primary Benefit | Targeted application | Higher potential efficacy |
Safety Considerations and Future Developments
Because oral minoxidil was designed as a powerful antihypertensive peripheral vasodilator, it can cause serious adverse effects. Specifically, there are concerns regarding cardiac risk when using the medication orally.
To address these concerns and the inconvenience of topical applications, new pharmaceutical developments are underway. Veradermics is currently developing VDPHL01, an extended-release oral minoxidil tablet specifically for androgenetic alopecia in both men and women. This formulation aims to minimize potential cardiac risks. The drug is currently in phase-three studies, including the first-ever phase-three study dedicated to female pattern hair loss.
Frequently Asked Questions
Is oral minoxidil better than topical minoxidil?
Some clinical data suggests that 5 mg/day of oral minoxidil is more effective than 2% or 5% topical versions for male androgenetic alopecia after six months. However, oral use is off-label and carries different risk profiles than topical use.
Who can use minoxidil for hair loss?
Minoxidil is used by both men and women to treat androgenetic alopecia. Topical versions are FDA-approved for both, while low-dose oral versions are used off-label for both genders, as well as for chronic telogen effluvium in women.
How does minoxidil actually grow hair?
It acts as a potassium channel opener and vasodilator. It similarly serves as an anti-inflammatory agent and induces the Wnt/β-catenin signaling pathway, which helps prolong the growth phase (anagen) of the hair follicle.